OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021
MIAMI, July 20, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for...
News
Rain Therapeutics Initiates Phase 3 MANTRA Clinical Trial of Milademetan for De-differentiated Liposarcoma and Provides Patient Update from Prior Clinical Program
The randomized, multi-center, open-label Phase 3 trial will evaluate the efficacy and safety of milademetan in patients with de-differentiated (DD)...
Eyenuk Announces $6.2 Million Financing to Accelerate Adoption of FDA-cleared AI Technology for Detection of Diabetic Retinopathy
Financing led by AXA IM’s Impact Investing strategyLOS ANGELES, July 20, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial...
ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR RAPID EXTRACTION METHOD ON PROPRIETARY TEST SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2
NEW YORK, NY, July 20, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences...
CoLabs Announces Regulation A+ Stock Offering in its Reimagined Skincare Delivery Technology QuantaSphere® and Growing Business
Common Stock in the Biotech Firm Will Allow All Investors to Share Ownership in the Company with a New Patented...
Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a FOCUS-C9 Clinical Trial of WVE-004 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
First clinical dosing of a compound using PN backbone chemistry modifications Enrolling participants with C9-ALS, C9-FTD or mixed phenotype FOCUS-C9...
HTG Forms New Drug Discovery Business Unit
New unit to focus on development of drug candidates through use of HTG Transcriptome PanelTUCSON, Ariz., July 20, 2021 (GLOBE...
CV Sciences, Inc. and University of California, San Diego Publish Study of Cannabidiol Efficacy in Treating Nicotine Dependence
SAN DIEGO, July 20, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”),...
Recce Pharmaceuticals Announces Lead Synthetic Anti-infective RECCE® 327 Demonstrates Outstanding Efficacy Against Necrotizing Fasciitis ‘Flesh-Eating’ Bacteria
Figure 1 Bactericidal activity of R327 on C. perfringens Figure 2 Bactericidal activity of R327 on S. pyogenes ATCC 19615...
MIMEDX to Host Second Quarter 2021 Operating and Financial Results Conference Call on August 4
MARIETTA, Ga., July 20, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader...
Arbor Strengthens Focus on Therapeutics with Key Additions to Leadership Team
- Pam Stetkiewicz, Ph.D., Appointed Chief Operating Officer - Kathryn McCabe, Ph.D., Named SVP, Head of Business Development CAMBRIDGE, Mass.,...
Rick Ware Racing Taps Clubhouse Media’s 400 Million Follower Influencer Network to Drive Brand Traction with New Generation of Racing Fans
Company Announces Joint Services Agreement with Top NASCAR and IndyCar Race Team -- Clubhouse Media Will Also be Featured on...
180 Life Sciences Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)
PALO ALTO, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the...
Alignment Healthcare Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance
ORANGE, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Medicare Advantage company (NASDAQ: ALHC) Alignment Healthcare today announced that its core...
Mindset Pharma Announces Appointment of Clinician Scientist, Dr. Ishrat Husain, to Scientific Advisory Board
TORONTO, July 20, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"),...
Beyond Air® Schedules First Fiscal Quarter 2022 Financial Results Conference Call and Webcast
Call scheduled for Tuesday, August 10th at 4:30 pm Eastern TimeGARDEN CITY, N.Y., July 20, 2021 (GLOBE NEWSWIRE) -- Beyond...
SpringWorks Therapeutics Announces Issuance of New U.S. Composition of Matter Patent to Polymorphic Form of Mirdametinib, Extending Patent Protection Into 2041
STAMFORD, Conn., July 20, 2021 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) announced today that the United States Patent...
AREV Annual and Special General Meeting Results
Appoints Mel Maxwell as an AREV DirectorVANCOUVER, British Columbia, July 20, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE:...
Affinia Therapeutics Announces Collaboration with the Institute of Molecular and Clinical Ophthalmology Basel (IOB) To Rationally Design Novel CNS Promoters for Gene Therapy
– Botond Roska, M.D., Ph.D., world-renowned scientist and Director at IOB and scientific co-founder of Affinia Therapeutics, will oversee collaboration – –...
Novartis pledges 10-year commitment with Morehouse School of Medicine, 26 Historically Black Colleges, Universities, Medical Schools and other leading organizations to co-create effective, measurable solutions for health equity
Novartis and the Novartis US Foundation to join forces with Thurgood Marshall College Fund, Morehouse School of Medicine, 26 other...